Lung Cancer Canada, The Lung Ambition Alliance, and AstraZeneca Canada announced a call for nominations for the 2025 Lung Ambition Awards. The Canadian-based lung cancer research awards program is designed to help improve the lives of people living with lung cancer. The grant program is open to all Canadian clinicians and researchers (across the multi-disciplinary spectrum) who work in the lung cancer space. The awards support research in lung cancer within the following areas:
- Enhancing Early Detection: Including research into methodologies like screening, incidental pulmonary nodules and blood-based testing, particularly for those individuals not meeting current screening criteria.
- Improving Healthcare and Patient Systems: Including ways in which institutions or health care systems can improve care along the patient pathway.
- Addressing Disparities to Improve Equity: Including the identification of systemic barriers and ways to overcome them.
Submissions will be accepted until February 7, 2025.
For further information about the Lung Ambition Awards Program or to apply, click here.